• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲氨蝶呤对小鼠肝脏的组织病理学影响。

Histopathological effects of methotrexate on mouse liver.

作者信息

Baskerville A, Cox S

出版信息

Br J Exp Pathol. 1978 Jun;59(3):327-31.

PMID:678449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2041357/
Abstract

Mice were injected with up to 9 doses of methotrexate and killed at intervals after treatment. Liver changes were assessed histopathologically and by image analysis, and included vacuolation and ballooning degeneration of centrilobular liver cells. There was considerable irregularity in nuclear size in methotrexate-treated mice, in which hepatic nuclei were significantly larger than those of control animals. Fatty change was not induced in the liver by these doses of methotrexate, and there was no cellular infiltration or fibrosis.

摘要

给小鼠注射多达9剂甲氨蝶呤,并在治疗后的不同时间点处死。通过组织病理学和图像分析评估肝脏变化,包括中央小叶肝细胞的空泡化和气球样变性。甲氨蝶呤治疗的小鼠细胞核大小存在相当大的不规则性,其中肝细胞核明显大于对照动物的肝细胞核。这些剂量的甲氨蝶呤未在肝脏中诱导脂肪变性,也没有细胞浸润或纤维化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1970/2041357/c35242e0d0cc/brjexppathol00129-0104-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1970/2041357/7db013aa1907/brjexppathol00129-0104-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1970/2041357/af27b5a139bd/brjexppathol00129-0104-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1970/2041357/5f4243714cbd/brjexppathol00129-0104-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1970/2041357/c35242e0d0cc/brjexppathol00129-0104-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1970/2041357/7db013aa1907/brjexppathol00129-0104-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1970/2041357/af27b5a139bd/brjexppathol00129-0104-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1970/2041357/5f4243714cbd/brjexppathol00129-0104-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1970/2041357/c35242e0d0cc/brjexppathol00129-0104-d.jpg

相似文献

1
Histopathological effects of methotrexate on mouse liver.甲氨蝶呤对小鼠肝脏的组织病理学影响。
Br J Exp Pathol. 1978 Jun;59(3):327-31.
2
NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.美国国家毒理学计划关于灌胃给予F344大鼠和B6C3F1小鼠瑞得灵(化学物质登记号:23246-96-0)的毒性研究技术报告
Toxic Rep Ser. 1993 Dec;27:1-D9.
3
NTP Toxicology and Carcinogenesis Studies of Pyridine (CAS No. 110-86-1) in F344/N Rats, Wistar Rats, and B6C3F1 Mice (Drinking Water Studies).NTP对F344/N大鼠、Wistar大鼠和B6C3F1小鼠进行的吡啶(CAS编号110 - 86 - 1)毒理学和致癌性研究(饮用水研究)
Natl Toxicol Program Tech Rep Ser. 2000 Mar;470:1-330.
4
Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate.
J Rheumatol. 1989 Apr;16(4):489-93.
5
NTP Toxicology and Carcinogenesis Studies of Bromodichloromethane (CAS No. 75-27-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
Natl Toxicol Program Tech Rep Ser. 1987 Oct;321:1-182.
6
NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).香豆素(CAS编号91-64-5)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340.
7
Toxicology and carcinogenesis studies of 3,3',4,4'-tetrachloroazobenzene (TCAB) (CAS No. 14047-09-7) in Harlan Sprague-Dawley rats and B6C3F1 mice (gavage studies).3,3',4,4'-四氯偶氮苯(TCAB)(化学物质登记号:14047-09-7)在哈兰斯普拉格-道利大鼠和B6C3F1小鼠中的毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 2010 Nov(558):1-206.
8
NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).五氯苯甲醚(CAS编号:1825-21-4)在F344大鼠和B6C3F1小鼠中的NTP毒理学与致癌性研究(饲料喂养研究)
Natl Toxicol Program Tech Rep Ser. 1993 Apr;414:1-284.
9
Gene expression profiles of murine fatty liver induced by the administration of methotrexate.甲氨蝶呤诱导的小鼠脂肪肝的基因表达谱
Toxicology. 2008 Jul 10;249(1):75-84. doi: 10.1016/j.tox.2008.04.011. Epub 2008 Apr 22.
10
NTP Toxicology and Carcinogenesis Studies of para-Chloroaniline Hydrochloride (CAS No. 20265-96-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).盐酸对氯苯胺(CAS编号:20265-96-7)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学与致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1989 Jul;351:1-256.

本文引用的文献

1
METHOTREXATE DISPLACEMENT IN MAN.人体内甲氨蝶呤的置换
J Clin Invest. 1964 Apr;43(4):621-9. doi: 10.1172/JCI104947.
2
The relation of folic acid reductase to aminopterin toxicity.叶酸还原酶与氨甲蝶呤毒性的关系。
J Pharmacol Exp Ther. 1962 Aug;137:167-72.
3
Hepatic fibrosis in children with acute leukemia after therapy with folic acid antagonists.急性白血病患儿接受叶酸拮抗剂治疗后的肝纤维化
AMA Arch Pathol. 1955 Feb;59(2):198-206.
4
Cirrhosis associated with methotrexate treatment of psoriasis.与甲氨蝶呤治疗银屑病相关的肝硬化。
JAMA. 1968 Nov 11;206(7):1515-20.
5
Liver damage due to methotrexate in patients with psoriasis.银屑病患者中因甲氨蝶呤导致的肝损伤。
Br Med J. 1971 Mar 20;1(5750):625-30. doi: 10.1136/bmj.1.5750.625.
6
Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens.银屑病中甲氨蝶呤的肝毒性——不同剂量方案的比较
Br Med J. 1972 Mar 11;1(5801):654-6. doi: 10.1136/bmj.1.5801.654.
7
Methotrexate induced liver disease in psoriasis.
Br J Dermatol. 1974 Jun;90(6):661-7. doi: 10.1111/j.1365-2133.1974.tb06695.x.
8
Effects of methotrexate on the liver in psoriasis.甲氨蝶呤对银屑病肝脏的影响。
J Invest Dermatol. 1974 Jun;62(6):597-602. doi: 10.1111/1523-1747.ep12679887.
9
A prospective study of the effects of weekly oral methotrexate on liver biopsy.一项关于每周口服甲氨蝶呤对肝脏活检影响的前瞻性研究。
Br J Dermatol. 1975 Sep;93(3):321-7. doi: 10.1111/j.1365-2133.1975.tb06498.x.